Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Shareholders' Equity (Unaudited)

v3.20.1
Condensed Statements of Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Sep. 30, 2018 13,646,553      
Balance at Sep. 30, 2018 $ 136,466 $ 55,483,759 $ 13,254,651 $ 68,874,876
Stock-based compensation expense   1,102,190   1,102,190
Restricted stock issuance, net (in shares) 352      
Restricted stock issuance, net $ (4) 4    
Net income     1,377,902 1,377,902
Restricted stock issuance, net (in shares) (352)      
Exercise of stock options, net of shares exchanged for payment (in shares) 5,440      
Exercise of stock options, net of shares exchanged for payment $ 54 (30) 24
Issuance of common stock under employee stock purchase plan (in shares) 17,312      
Issuance of common stock under employee stock purchase plan $ 173 145,767 145,940
Tax withholding related to vesting of restricted stock grants (in shares) (545)      
Tax withholding related to vesting of restricted stock grants $ (5) (6,671) (6,676)
Balance (in shares) at Mar. 31, 2019 13,668,408      
Balance at Mar. 31, 2019 $ 136,684 56,725,019 14,632,553 71,494,256
Balance (in shares) at Dec. 31, 2018 13,662,456      
Balance at Dec. 31, 2018 $ 136,625 56,161,405 14,264,611 70,562,641
Stock-based compensation expense   563,666   563,666
Restricted stock issuance, net (in shares) (3,486)      
Restricted stock issuance, net $ 35 (35)    
Net income     367,942 367,942
Restricted stock issuance, net (in shares) 3,486      
Exercise of stock options, net of shares exchanged for payment (in shares) 2,466      
Exercise of stock options, net of shares exchanged for payment $ 24 (17) 7
Balance (in shares) at Mar. 31, 2019 13,668,408      
Balance at Mar. 31, 2019 $ 136,684 56,725,019 14,632,553 71,494,256
Balance (in shares) at Sep. 30, 2019 13,641,805      
Balance at Sep. 30, 2019 $ 136,418 56,976,162 17,820,807 74,933,387
Repurchase of common stock (in shares) (41,796)      
Repurchase of common stock $ (418) (428,236) (428,654)
Stock-based compensation expense   328,523   328,523
Restricted stock issuance, net (in shares) 9,580      
Restricted stock issuance, net $ 96 (96)
Exercise of stock options (in shares)       4,000
Net income     1,249,055 $ 1,249,055
Restricted stock issuance, net (in shares) (9,580)      
Exercise of stock options, net of shares exchanged for payment (in shares) 3,396      
Exercise of stock options, net of shares exchanged for payment $ 33 2,549 2,582
Issuance of common stock under employee stock purchase plan (in shares) 15,107      
Issuance of common stock under employee stock purchase plan $ 151 169,501 169,652
Tax withholding related to vesting of restricted stock grants (in shares) (453)      
Tax withholding related to vesting of restricted stock grants $ (4) (5,799) (5,803)
Balance (in shares) at Mar. 31, 2020 13,627,639      
Balance at Mar. 31, 2020 $ 136,276 57,042,604 19,069,862 76,248,742
Balance (in shares) at Dec. 31, 2019 13,657,459      
Balance at Dec. 31, 2019 $ 136,575 57,383,020 18,321,965 75,841,560
Repurchase of common stock (in shares) (41,796)      
Repurchase of common stock $ (418) (428,236) (428,654)
Stock-based compensation expense   87,937   87,937
Restricted stock issuance, net (in shares) 9,580      
Restricted stock issuance, net $ 96 (96)
Exercise of stock options (in shares) 2,396      
Exercise of stock options $ 23 (21) 2
Net income     747,897 747,897
Restricted stock issuance, net (in shares) (9,580)      
Balance (in shares) at Mar. 31, 2020 13,627,639      
Balance at Mar. 31, 2020 $ 136,276 $ 57,042,604 $ 19,069,862 $ 76,248,742